Skip to main content
SNWV logo

SNWV · SANUWAVE Health, Inc.

Track SNWV — free
$4.45 -0.15 (-3.26%) At close · Sep 2
Market Cap
$40.09M
Shares
8.60M

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue
$44.05M +35%
FY2025 Revenue FY2010–FY2025
Net Income
$11.81M +135.7%
FY2025 Net Income FY2010–FY2025
Gross Margin
77.11% +1.9pp
FY2025 Gross Margin FY2010–FY2025
Operating Margin
11.23% -0.6pp
FY2025 Operating Margin FY2010–FY2025
Diluted EPS
$0.41 +105.5%
FY2025 Diluted EPS FY2010–FY2025
Operating Cash Flow
$3.88M +57.9%
FY2025 Operating Cash Flow FY2010–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
$44.02M $44.05M $32.63M $20.4M $16.74M $13.01M $4.06M $1.53M $1.85M $738.53K $1.38M $965.5K $847.37K $800.03K $769.22K $802.57K $728.45K
$145K $303K $1.14M $1.23M $1.63M $429K
$10.42M $10.08M $8.08M $6.04M $4.33M $4.99M $1.16M $538.92K $693.66K $241.97K $565.13K $284.96K $219.98K $189.79K $220.26K $261.89K $250.33K
$33.6M $33.97M $24.55M $14.36M $12.41M $8.02M $2.9M $489.81K $1.16M $496.56K $680.54K $627.39K $610.24K $548.96K $540.68K $478.12K
77.11% 75.23% 70.41% 74.13% 61.68% 71.36% 32.04% 62.51% 67.24% 70.49% 74.04% 76.28% 71.37% 67.37% 65.64%
$2.24M $1.35M $673K $579K $567K $1.1M $1.25M $1.18M $981.65K $1.29M $1.13M $2.17M $3M $2.3M $1.76M $2.73M $3.88M
$8.54M $7.42M $6.32M $4.9M $7.47M $8.59M $5.16M $1.59M $521.41K
$20.31M $19.37M $12.92M $8.67M $12.56M $11.69M $13.72M $6.44M $6.81M $3M $2.67M $2.74M $3.27M $3.96M $4.52M $6.29M $7.1M
$704K $704K $704K $704K $704K $713K $0 $0 $306.76K $306.76K $306.76K $306.76K $306.76K $306.76K $306.76K
$1.14M $974K $788K $1.03M $952K $1.24M $299K $71.21K
$32.1M $29.02M $20.7M $14.9M $21.36M $22.17M $28.1M $9.28M $8.34M $4.32M $4.13M $5.12M $6.59M $6.59M $6.61M $9.35M $12.29M
$590K $482K $484K $324K $377K
$1.5M $4.95M $3.85M -$540K -$8.95M -$14.14M -$25.2M -$8.79M -$7.18M -$3.82M -$3.32M -$4.44M -$5.96M -$5.98M -$6.06M -$8.81M -$11.81M
11.23% 11.79% -2.65% -53.47% -108.7% -621.15% -575.27% -388.11% -517.85% -241.01% -459.63% -703.77% -746.97% -788.12% -1097.61% -1620.92%
$2.64M $5.92M $4.64M $488K -$8M -$12.91M -$24.9M -$8.72M
$1.09M $1.84M $4.5M $1.14M $854.98K $399.83K $433.78K $360.27K $323.23K $472.16K $961.59K
$13.85M $6.95M -$36.9M -$25.26M -$1.34M -$13.09M -$5.74M -$1.64M -$4.45M -$1.71M -$3.12M -$372.51K -$10.59K -$1.43M -$3.35M
$11.9M -$33.06M -$5.97M -$11.95M -$6.4M -$10.24M -$15.16M
$86K $27K $4000 $2000 $28K $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 -$239.97K
$15.26M $11.81M -$33.08M -$25.81M -$10.29M -$27.26M -$30.94M -$10.43M -$11.63M -$5.54M -$6.44M -$4.81M -$5.97M -$11.3M -$6.4M -$10.24M -$14.92M
26.82% -101.38% -126.52% -61.48% -209.52% -762.56% -682.26% -628.7% -749.86% -467.93% -498.22% -705.02% -1412.41% -832.21% -1275.75% -2048.53%
$16.49M $11.81M -$32.96M -$25.85M -$10.29M -$27.27M -$30.94M -$10.41M -$11.65M -$5.53M -$6.46M -$4.83M -$5.99M -$11.31M -$6.4M -$10.24M
USD/shares $1.79 $1.38 -$7.41 -$12.19 -$0.02 -$0.05 -$0.08 -$0.05 -$0.30 -$0.52 -$1.15
USD/shares $0.92 $0.41 -$7.41 -$12.19 -$0.02 -$0.05 -$0.08 -$0.05 -$0.30 -$0.52 -$1.15
shares 8.56M 4.46M 2.12M 549.47M 518.36M 378.13M 203.59M 149.54M 138.84M 107.62M 63.03M 48.21M 28.13M 20.92M 19.62M 12.92M
shares 9.08M 4.46M 2.12M 549.47M 518.36M 378.13M 203.59M 149.54M 138.84M 107.62M 63.03M 48.21M 28.13M 20.92M 19.62M 12.92M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
1.13×
Peer median 1.55×
EV/EBIT
33.17×
P/E (TTM)
Peer median 24.92×

Peer medians compare against the 68 similar-size Medical Devices companies (of 145 listed).

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (USD)

Component FY2025 FY2024 FY2023
Reportable Segment $44,051,000 $32,634,000 $20,398,000

By Geography (USD)

Component FY2024 FY2023 FY2022 FY2021 FY2020
United States $32,399,000 $20,168,000 $16,483,000 $12,298,000 $3,729,000
Non Us $235,000 $230,000 $259,000 $712,000 $328,000

By Product & Service (USD)

Component FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
Consumables Parts and Accessories Revenue $25,804,000 $21,116,000
System Revenue $17,849,000 $11,072,000 $5,957,000
Other Revenue $206,000 $306,000
Extended Warranty $172,000 $95,000
License Fees $20,000 $45,000
Accessory and Parts $8,072,000 $1,209,000
Accessory and Parts Revenue $1,209,000
Consumables and Parts $13,222,000 $9,862,000
License and Other $152,000
License Fees and Other $76,000 $321,000 $195,000 $152,000
Rental Income $429,000
Product $5,328,000 $3,116,000 $2,267,000

Segment Operating Income

Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.

By Segment (USD)

Component FY2025 FY2024 FY2023
Reportable Segment $4,945,000 $3,848,000 -$540,000

Operating Margin by Segment (%)

Component FY2025 FY2024 FY2023
Reportable Segment 11.2% 11.8% -2.6%
Key facts CIK 1417663 CUSIP 80303D305 13F (30d) 45 filings 44 filers Visit website Investor relations